Adjusted Gapss Antiphospholipid Syndrome Risk

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
agapss
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • High risk≥ 10
  • Moderate risk≥ 6
  • Lower risk≥ 0
Direct Clinical Answer

The Adjusted Gapss Antiphospholipid Syndrome Risk calculates determining thromboembolic risk, heparin-induced thrombocytopenia probability, and bleeding diathesis. Key inputs include acl. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Adjusted GAPSS: thrombotic risk in antiphospholipid syndrome.

Clinical Indication

The Adjusted Gapss Antiphospholipid Syndrome Risk is indicated for bedside clinical practice to support Adjusted GAPSS: thrombotic risk in antiphospholipid syndrome.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.

Limitations & Contraindications

Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention. Clinical exclusion: Adjusted GAPSS excludes anti-phosphatidylserine/prothrombin..

Clinical Pearls & Action Plan

Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies.

Formula & Variables:

aCL 5 + anti-b2GP1 4 + LA 4 + hyperlipidemia 3 + hypertension 1; total 0-17.

Input Parameters

NameTypeRequiredDescription
aclstringYesAnticardiolipin antibodies: yes, no
anti_b2gp1stringYesAnti-beta2-glycoprotein I: yes, no
lupus_anticoagulantstringYesLupus anticoagulant: yes, no
hyperlipidemiastringYesHyperlipidemia: yes, no
hypertensionstringYesArterial hypertension: yes, no

Score Interpretation & Guidance

RangeStageDescription
≥ 10High riskHigh thrombotic risk
≥ 6Moderate riskModerate risk
≥ 0Lower riskLower risk

Evidence-Based References (EBM)

  • Sciascia S, Sanna G, Murru V, et al. GAPSS: the Global Anti-Phospholipid Syndrome Score. Rheumatology. 2013;52(8):1397-1403.

Related calculators